Pharmacological inhibition of receptor protein tyrosine phosphatase β/ζ decreases Aβ plaques and neuroinflammation in the hippocampus of APP/PS1 mice DOI Creative Commons
Teresa Fontán‐Baselga, Héctor Cañeque‐Rufo,

Elisa Rivera-Illades

et al.

Frontiers in Pharmacology, Journal Year: 2024, Volume and Issue: 15

Published: Dec. 6, 2024

Alzheimer's disease (AD) is a major neurodegenerative disorder that courses with chronic neuroinflammation. Pleiotrophin (PTN) an endogenous inhibitor of Receptor Protein Tyrosine Phosphatase (RPTP) β/ζ which upregulated in different neuroinflammatory disorders diverse origin, including AD. To investigate the role RPTPβ/ζ neuroinflammation and neurodegeneration, we used eight-to ten-month-old APP/PS1 AD mouse model. They were administered intragastrically MY10, RPTPβ/ζ, at doses (60 90 mg/kg) every day for 14 days. Treatment mg/kg MY10 significantly reduced number size amyloid beta (Aβ) plaques dorsal subiculum hippocampus mice. In addition, observed significant decrease astrocytes both sexes microglial cells sex-dependent manner. This suggests plays important modulating Aβ plaque formation influences glial responses, may contribute to improved clearance. treatment decreased interaction Furthermore, analysis proinflammatory markers revealed mRNA levels

Language: Английский

Astrocytic pleiotrophin deficiency in the prefrontal cortex contributes to stress-induced depressive-like responses in male mice DOI Creative Commons
Dongmei Chi, Kun Zhang, Jianxing Zhang

et al.

Nature Communications, Journal Year: 2025, Volume and Issue: 16(1)

Published: March 14, 2025

Astrocytes are closely linked to depression, and the prefrontal cortex (PFC) is an important brain region involved in major depressive disorder (MDD). However, underlying mechanism by which astrocytes within PFC contribute MDD remains unclear. Using single-nucleus RNA sequencing analyses, we show a significant reduction attenuated pleiotrophin-protein tyrosine phosphatase receptor type Z1 (PTN-PTPRZ1) signaling astrocyte-to-excitatory neuron communication of male patients. We find reduced PTN dorsomedial mice with depression induced chronic restraint social defeat stress. Knockdown astrocytic induces depression-related responses, reversed exogenous supplementation or overexpression PTN. The antidepressant effects exerted require interaction PTPRZ1 excitatory neurons, PTN-PTPRZ1 activates AKT pathway regulate responses. Our findings indicate PTN-PTPRZ1-AKT may be potential therapeutic target for MDD. but mechanisms remain Here, authors that pleiotrophin contributes depression-like phenotype mice.

Language: Английский

Citations

0

Pharmacological inhibition of receptor protein tyrosine phosphatase β/ζ decreases Aβ plaques and neuroinflammation in the hippocampus of APP/PS1 mice DOI Creative Commons
Teresa Fontán‐Baselga, Héctor Cañeque‐Rufo,

Elisa Rivera-Illades

et al.

Frontiers in Pharmacology, Journal Year: 2024, Volume and Issue: 15

Published: Dec. 6, 2024

Alzheimer's disease (AD) is a major neurodegenerative disorder that courses with chronic neuroinflammation. Pleiotrophin (PTN) an endogenous inhibitor of Receptor Protein Tyrosine Phosphatase (RPTP) β/ζ which upregulated in different neuroinflammatory disorders diverse origin, including AD. To investigate the role RPTPβ/ζ neuroinflammation and neurodegeneration, we used eight-to ten-month-old APP/PS1 AD mouse model. They were administered intragastrically MY10, RPTPβ/ζ, at doses (60 90 mg/kg) every day for 14 days. Treatment mg/kg MY10 significantly reduced number size amyloid beta (Aβ) plaques dorsal subiculum hippocampus mice. In addition, observed significant decrease astrocytes both sexes microglial cells sex-dependent manner. This suggests plays important modulating Aβ plaque formation influences glial responses, may contribute to improved clearance. treatment decreased interaction Furthermore, analysis proinflammatory markers revealed mRNA levels

Language: Английский

Citations

1